Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Translational Lung Cancer Research|May 23, 2017
Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiationJonathan E Schoenhals, Steven N Seyedin, Clark Anderson, et al.Journal for Immunotherapy of Cancer|June 26, 2020
Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunityDawei Chen, Hampartsoum B Barsoumian, Grant Fischer, et al.Frontiers in Immunology|November 12, 2020
Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic ApproachesKatherine Klein, Kewen He, Ahmed I Younes, et al.Immunotherapy|February 10, 2018
Radiation therapy and immunotherapy: what is the optimal timing or sequencing?Maureen L Aliru, Jonathan E Schoenhals, Bhanu P Venkatesulu, et al.Cancer Immunology Research|April 18, 2020
SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti-PD-1-Resistant Model of Non-Small Cell Lung CancerDawei Chen, Hampartsoum B Barsoumian, Liangpeng Yang, et al.American Journal of Clinical Pathology|October 5, 2022
A Quantitative and Qualitative Assessment of Frozen Section Diagnosis Accuracy and Deferral Rate Across Organ SystemsAnas Mohamed, Muhammad Masood Hassan, Wen Zhong, et al.Cancers|January 11, 2022
High Plus Low Dose Radiation Strategy in Combination with TIGIT and PD1 Blockade to Promote Systemic Antitumor ResponsesHampartsoum B Barsoumian, Duygu Sezen, Hari Menon, et al.Cancer Letters|May 11, 2018
Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cellsAilin Li, Hampartsoum B Barsoumian, Jonathan E Schoenhals, et al.International Journal of Radiation Oncology, Biology, Physics|July 9, 2021
Radiation Therapy Enhanced by NBTXR3 Nanoparticles Overcomes Anti-PD1 Resistance and Evokes Abscopal EffectsYun Hu, Sébastien Paris, Hampartsoum Barsoumian, et al.Translational Oncology|December 19, 2020
Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activityAhmed I Younes, Hampartsoum B Barsoumian, Duygu Sezen, et al.Pageof 3